HK1029043A1 - Remedy for neurodegenerative diseases. - Google Patents
Remedy for neurodegenerative diseases.Info
- Publication number
- HK1029043A1 HK1029043A1 HK00106879A HK00106879A HK1029043A1 HK 1029043 A1 HK1029043 A1 HK 1029043A1 HK 00106879 A HK00106879 A HK 00106879A HK 00106879 A HK00106879 A HK 00106879A HK 1029043 A1 HK1029043 A1 HK 1029043A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- neurodegenerative diseases
- remedy
- disease
- medicament
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP36931397 | 1997-12-26 | ||
PCT/JP1998/005757 WO1999033465A1 (en) | 1997-12-26 | 1998-12-21 | Remedy for neurodegenerative diseases___________________________ |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1029043A1 true HK1029043A1 (en) | 2001-03-23 |
Family
ID=18494113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00106879A HK1029043A1 (en) | 1997-12-26 | 2000-10-30 | Remedy for neurodegenerative diseases. |
Country Status (12)
Country | Link |
---|---|
US (1) | US6342515B1 (ko) |
EP (1) | EP1040830B1 (ko) |
JP (1) | JP3364481B2 (ko) |
KR (1) | KR100508393B1 (ko) |
CN (1) | CN1149084C (ko) |
AT (1) | ATE297204T1 (ko) |
CA (1) | CA2317044C (ko) |
DE (1) | DE69830512T2 (ko) |
ES (1) | ES2244103T3 (ko) |
HK (1) | HK1029043A1 (ko) |
PT (1) | PT1040830E (ko) |
WO (1) | WO1999033465A1 (ko) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1332363A4 (en) * | 2000-10-09 | 2007-08-29 | Kay Double | PROOF OF NEURODEGENERATIVE DISEASES |
US7109198B2 (en) * | 2002-05-17 | 2006-09-19 | Duke University | Method for treating obesity |
US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
EP1539145A2 (en) * | 2002-09-13 | 2005-06-15 | Eisai Co., Ltd. | Method of treating tremors |
US20050059718A1 (en) * | 2003-02-21 | 2005-03-17 | Hayato Miyachi | Methods of using zonisamide as an adjunctive therapy for partial seizures |
EP2316456B1 (en) | 2003-04-29 | 2017-06-14 | Orexigen Therapeutics, Inc. | Compositions for affecting weight loss comprising an opioid antagonist and bupropion |
US20050043773A1 (en) * | 2003-08-21 | 2005-02-24 | Ivan Lieberburg | Methods of improving the safety of zonisamide therapy |
US20050043704A1 (en) * | 2003-08-21 | 2005-02-24 | Eisai Co., Ltd | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154034A1 (en) * | 2004-01-08 | 2005-07-14 | Eisai Co., Ltd. | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154032A1 (en) * | 2004-01-08 | 2005-07-14 | Eisai Co., Ltd | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154033A1 (en) * | 2004-01-08 | 2005-07-14 | Eisai Co., Ltd | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154036A1 (en) * | 2004-01-09 | 2005-07-14 | Eisai Co., Ltd. | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154037A1 (en) * | 2004-01-09 | 2005-07-14 | Eisai Co., Ltd. | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154035A1 (en) * | 2004-01-09 | 2005-07-14 | Eisai Co., Ltd. | Methods of using zonisamide as an adjunctive therapy for partial seizures |
WO2006023703A2 (en) * | 2004-08-20 | 2006-03-02 | Cypress Bioscience, Inc. | Method for treating sleep related breathing disorders |
EP1913935A1 (en) * | 2005-01-21 | 2008-04-23 | Teva Pharmaceutical Industries Ltd | Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
DE602006014607D1 (de) * | 2005-01-21 | 2010-07-15 | Teva Pharma | Stabile pharmazeutische Zusammensetzungen von Zonisamide und Verfahren zur deren Herstellung |
US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
EP1951212A2 (en) | 2005-11-22 | 2008-08-06 | Orexigen Therapeutics, Inc. | Compositions and methods for increasing insulin sensitivity |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
TW201811315A (zh) | 2006-11-09 | 2018-04-01 | 美商歐瑞根治療有限公司 | 層狀醫藥調配物 |
KR20090090316A (ko) | 2006-11-09 | 2009-08-25 | 오렉시젠 세러퓨틱스 인크. | 체중 감량 약물을 투여하기 위한 단위 용량 팩키지 및 투여 방법 |
WO2009054543A1 (en) * | 2007-10-26 | 2009-04-30 | Eisai R & D Management Co., Ltd. | Ampa receptor antagonists and zonisamide for parkinson's disease and movement disorders |
NZ589304A (en) | 2008-04-29 | 2012-03-30 | Pharnext | Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate |
CA2725930A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
ES2762113T3 (es) | 2010-01-11 | 2020-05-22 | Nalpropion Pharmaceuticals Inc | Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor |
EP4104824A1 (en) | 2012-06-06 | 2022-12-21 | Nalpropion Pharmaceuticals LLC | Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk |
JP6155266B2 (ja) * | 2012-08-01 | 2017-06-28 | 大日本住友製薬株式会社 | ゾニサミドを含有する経皮吸収型製剤 |
WO2014119767A1 (ja) * | 2013-01-31 | 2014-08-07 | 沢井製薬株式会社 | テルミサルタンとヒドロクロロチアジドとを含有する多層錠剤 |
US20180271838A1 (en) * | 2015-09-30 | 2018-09-27 | National University Corporation Nagoya University | Pharmaceutical composition for treating and/or preventing peripheral neuropathy or spinal cord injury |
EP3668508A1 (en) | 2017-08-19 | 2020-06-24 | FTF Pharma Private Limited | An oral pharmaceutical composition comprising zonisamide and process of preparation thereof |
EP3928771A1 (en) * | 2020-06-23 | 2021-12-29 | Laboratorios Lesvi, S.L. | Pharmaceutical compositions of 1,2-benzisoxazole-3-methanesulfonamide |
US20230202991A1 (en) | 2020-07-07 | 2023-06-29 | Sumitomo Pharma Co., Ltd. | Benzisoxazole derivative |
JP7324953B2 (ja) * | 2022-01-12 | 2023-08-10 | 住友ファーマ株式会社 | ベンゾイソキサゾール誘導体を含有する医薬組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
WO1989006129A1 (en) * | 1987-12-29 | 1989-07-13 | Dainippon Pharmaceutical Co., Ltd. | Agent for treating ischemic brain trouble |
US5830910A (en) * | 1995-10-23 | 1998-11-03 | University Of Kentucky Research Foundation | Cytochalasins useful in providing protection against nerve cell injury associated with neurodegenerative disorders |
-
1998
- 1998-12-21 CN CNB98812680XA patent/CN1149084C/zh not_active Expired - Fee Related
- 1998-12-21 WO PCT/JP1998/005757 patent/WO1999033465A1/ja active IP Right Grant
- 1998-12-21 CA CA002317044A patent/CA2317044C/en not_active Expired - Fee Related
- 1998-12-21 DE DE69830512T patent/DE69830512T2/de not_active Expired - Lifetime
- 1998-12-21 PT PT98961430T patent/PT1040830E/pt unknown
- 1998-12-21 KR KR10-2000-7007033A patent/KR100508393B1/ko not_active IP Right Cessation
- 1998-12-21 AT AT98961430T patent/ATE297204T1/de active
- 1998-12-21 JP JP2000526222A patent/JP3364481B2/ja not_active Expired - Lifetime
- 1998-12-21 US US09/582,433 patent/US6342515B1/en not_active Expired - Fee Related
- 1998-12-21 ES ES98961430T patent/ES2244103T3/es not_active Expired - Lifetime
- 1998-12-21 EP EP98961430A patent/EP1040830B1/en not_active Expired - Lifetime
-
2000
- 2000-10-30 HK HK00106879A patent/HK1029043A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100508393B1 (ko) | 2005-08-17 |
EP1040830B1 (en) | 2005-06-08 |
EP1040830A4 (en) | 2002-10-23 |
CA2317044A1 (en) | 1999-07-08 |
DE69830512D1 (de) | 2005-07-14 |
KR20010015890A (ko) | 2001-02-26 |
ATE297204T1 (de) | 2005-06-15 |
CN1283113A (zh) | 2001-02-07 |
EP1040830A1 (en) | 2000-10-04 |
DE69830512T2 (de) | 2006-03-23 |
JP3364481B2 (ja) | 2003-01-08 |
CN1149084C (zh) | 2004-05-12 |
ES2244103T3 (es) | 2005-12-01 |
WO1999033465A1 (en) | 1999-07-08 |
US6342515B1 (en) | 2002-01-29 |
PT1040830E (pt) | 2005-08-31 |
CA2317044C (en) | 2008-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1029043A1 (en) | Remedy for neurodegenerative diseases. | |
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
GB0108592D0 (en) | Therapeutic agents | |
AU684059B2 (en) | Application of riluzole in the treatment of Parkinson's disease and Parkinsonian syndromes | |
DK0589893T3 (da) | Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori | |
GB2288732B (en) | Pharmaceutical compositions | |
HU9603042D0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration | |
AU2711295A (en) | Combination treatment for inhibiting bone loss | |
BG105302A (en) | Means for improving cognition | |
IL120443A (en) | Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis | |
BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
BR9711259A (pt) | Droga preventiva ou terapeutica para doen-a de alzheimer | |
MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
AUPP823999A0 (en) | A treatment | |
EP0373771A3 (en) | New pharmaceutical uses for cystatins | |
GB9126874D0 (en) | Medicaments | |
ZA944281B (en) | Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease | |
NZ268914A (en) | Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease | |
HUP0004647A2 (hu) | Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
EP0891778A3 (en) | Agents for the prevention and/or treatment of radiation-induced disorders | |
WO1998036758A3 (de) | Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson | |
AU1870501A (en) | Combination of an ergoline and riluzole for preventing and treating motor neurondiseases | |
ITMI910442V0 (it) | Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce | |
AU2427300A (en) | Use of extracts from ginkgo biloba leaves for treating sleep disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20141221 |